Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00287599 · ClinicalTrials.gov registry record

Rapid Identification of Key Pathogens in Wound Infection by Molecular Means

A clinical trial, sponsored by Brentwood Biomedical Research Institute.

Completed
Registry status
400
Enrollment target

NCT00287599: Completed study, sponsored by Brentwood Biomedical Research Institute.

NCT00287599 is a clinical trial that has completed, run by Brentwood Biomedical Research Institute. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00287599 has completed, sponsored by Brentwood Biomedical Research Institute.

COMPLETED
Registry status
400 participants
Enrollment target

Study Summary

The military is subject to traumatic wounds of various types and severity. Such wounds are predisposed to infection because they 1) tend to be extensive and deep, 2) may affect areas of normal carriage of potentially pathogenic bacteria in the gastrointestinal tract, upper respiratory tract, and the female genital tract, 3) typically produce tissue damage, 4) may introduce foreign bodies, 5) may interfere with local blood supply, 6) tend to produce ischemia, edema and hemorrhage, 7) may be complicated by fractures or burns and 8) may lead to shock and overwhelming of the body's systemic defenses. It will not always be possible in the military setting to cleanse and debride the wound promptly and effectively or to promptly provide surgery in the event of damage to vital structures. In the active military setting, the probability of wound infection following trauma is relatively high. In the absence of rapid identification of infecting flora and provision of information on antimicrobial susceptibility, clinicians must resort to empiric therapy rather than a tailored therapy. There is a tendency to use one of the top available agents that would likely be active against the vast majority of bacteria. This leads to increases in antimicrobial resistance, an important problem. The investigators hypothesize that the use of molecular biology techniques will provide identification of the microorganisms responsible for wound infection more rapidly and accurately. The investigators will evaluate real-time PCR (polymerase chain reaction) technique under this proposal. This procedure can be applied directly to material from the wound without need for first growing the organisms. It can be used to define the total flora of the wound within five hours. The investigators will first develop primers and probes that will detect the various bacteria anticipated in a given wound in a certain location. These primers and probes will be used in real-time PCR for rapid and accurate identifi

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2006-10
Est. Completion 2011-08

What the finished NCT00287599 record still lists

NCT00287599 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00287599 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00287599 about?

NCT00287599 is a clinical study titled "Rapid Identification of Key Pathogens in Wound Infection by Molecular Means". The military is subject to traumatic wounds of various types and severity. Such wounds are predisposed to infection because they 1) tend to be extensive and deep, 2) may affect areas of normal carriage of potentially pathogenic bacteria in the gastrointestinal tract, upper respiratory tract, and the...

What is the current status of trial NCT00287599?

This trial is currently completed. The enrollment target is 400 participants. The study started on 2006-10. Estimated completion is 2011-08.

Who is sponsoring clinical trial NCT00287599?

This trial is sponsored by Brentwood Biomedical Research Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00287599, the US trial registry maintained by the National Library of Medicine. NCT00287599 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.